{"PubmedBookArticle": [], "PubmedArticle": [{"MedlineCitation": {"OtherAbstract": [], "CitationSubset": ["IM"], "OtherID": [], "GeneralNote": [], "SpaceFlightMission": [], "KeywordList": [], "InvestigatorList": [], "PMID": "7857511", "DateCompleted": {"Year": "1995", "Month": "03", "Day": "23"}, "DateRevised": {"Year": "2017", "Month": "02", "Day": "14"}, "Article": {"Language": ["eng"], "ArticleDate": [], "ELocationID": [], "Journal": {"ISSN": "0891-9887", "JournalIssue": {"Volume": "7 Suppl 1", "PubDate": {"Year": "1994", "Month": "Oct"}}, "Title": "Journal of geriatric psychiatry and neurology", "ISOAbbreviation": "J Geriatr Psychiatry Neurol"}, "ArticleTitle": "Inhibition of MAO by fractions and constituents of hypericum extract.", "Pagination": {"StartPage": "S57", "EndPage": "S59", "MedlinePgn": "S57-9"}, "Abstract": {"AbstractText": ["The inhibition of monoamine oxidase (MAO) by six fractions from hypericum extract and three characteristic constituents (as pure substances) were analyzed in vitro and ex vivo to study the antidepressive mechanism of action. Rat brain homogenates were used as the in vitro model, while the ex vivo analysis was performed after intraperitoneal application of the test substances to albino rats. Massive inhibition of MAO-A could be shown with the total extract and all fractions only at the concentration of 10(-3) mol/L. At 10(-4) mol/L, one fraction rich in flavonoides showed an inhibition of 39%, and all other fractions demonstrated less than 25% inhibition. Using pure hypericin as well as in all ex vivo experiments, no relevant inhibiting effects could be shown. From the results it can be concluded that the clinically proven antidepressive effect of hypericum extract cannot be explained in terms of MAO inhibition."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institut f\u00fcr Pharmazeutische Biologie der Universit\u00e4t M\u00fcnchen, Germany."}], "LastName": "Bladt", "ForeName": "S", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [], "LastName": "Wagner", "ForeName": "H", "Initials": "H"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "J Geriatr Psychiatry Neurol", "NlmUniqueID": "8805645", "ISSNLinking": "0891-9887"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Antidepressive Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Monoamine Oxidase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "0", "NameOfSubstance": "Xanthenes"}, {"RegistryNumber": "5QD5427UN7", "NameOfSubstance": "Perylene"}, {"RegistryNumber": "9IKM0I5T1E", "NameOfSubstance": "Quercetin"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Antidepressive Agents"}, {"QualifierName": [], "DescriptorName": "Hypericum"}, {"QualifierName": [], "DescriptorName": "In Vitro Techniques"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Monoamine Oxidase Inhibitors"}, {"QualifierName": ["analogs & derivatives", "chemistry", "pharmacology"], "DescriptorName": "Perylene"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["analogs & derivatives", "chemistry", "pharmacology"], "DescriptorName": "Quercetin"}, {"QualifierName": [], "DescriptorName": "Rats"}, {"QualifierName": ["chemistry", "pharmacology"], "DescriptorName": "Xanthenes"}]}, "PubmedData": {"ReferenceList": [], "History": [{"Year": "1994", "Month": "10", "Day": "1"}, {"Year": "1994", "Month": "10", "Day": "1", "Hour": "0", "Minute": "1"}, {"Year": "1994", "Month": "10", "Day": "1", "Hour": "0", "Minute": "0"}], "PublicationStatus": "ppublish", "ArticleIdList": ["7857511", "10.1177/089198879400700115"]}}]}